Outlook Therapeutics, Inc.

Q4 2022 13F Holders

Symbol: OTLK
CUSIP: 69012T305
Type: Equity
Class: COM
Num filings: 1
Total reported value, excl. options: $147 k

Compare 2022 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type